August 1, 2012 - Volume 60 - Issue 4 - Contributor Index

Mid-Dosing Interval Efavirenz Plasma Concentrations in HIV-1–Infected Children in Rwanda: Treatment Efficacy, Tolerability, Adherence, and the Influence of CYP2B6 Polymorphisms

Mutwa, Philippe R.; Fillekes, Quirine; Malgaz, Marie; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 60(4):400-404, August 1, 2012.

Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa

Fox, Matthew P.; Cutsem, Gilles Van; Giddy, Janet; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 60(4):428-437, August 1, 2012.

Time to Initiate Antiretroviral Therapy Between 4 Weeks and 12 Weeks of Tuberculosis Treatment in HIV-Infected Patients: Results From the TIME Study

Manosuthi, Weerawat; Mankatitham, Wiroj; Lueangniyomkul, Aroon; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 60(4):377-383, August 1, 2012.

Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa

Fox, Matthew P.; Cutsem, Gilles Van; Giddy, Janet; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 60(4):428-437, August 1, 2012.